Thierry Poynard

9.7k total citations · 2 hit papers
143 papers, 6.2k citations indexed

About

Thierry Poynard is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Thierry Poynard has authored 143 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Epidemiology, 81 papers in Hepatology and 27 papers in Surgery. Recurrent topics in Thierry Poynard's work include Liver Disease Diagnosis and Treatment (93 papers), Hepatitis C virus research (47 papers) and Liver Disease and Transplantation (31 papers). Thierry Poynard is often cited by papers focused on Liver Disease Diagnosis and Treatment (93 papers), Hepatitis C virus research (47 papers) and Liver Disease and Transplantation (31 papers). Thierry Poynard collaborates with scholars based in France, United States and Germany. Thierry Poynard's co-authors include Jean‐Pierre Benhamou, Didier Lebrec, Jean‐Claude Chaput, Philippe Mathurin, Pierre Bédossa, Vlad Ratziu, Patrick Hillon, Sylvie Naveau, B Rueff and Raluca Pais and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Thierry Poynard

139 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis

1981 375 citations Thierry Poynard, Jean‐Pierre Benhamou et al. New England Journal of Medicine profile →
NAFLD and liver transplantation: Current burden and expected challenges

2016 320 citations Raluca Pais, Pascal Lebray et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Thierry Poynard

Since Specialization

Citations

This map shows the geographic impact of Thierry Poynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Poynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Poynard more than expected).

Fields of papers citing papers by Thierry Poynard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Poynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Poynard. The network helps show where Thierry Poynard may publish in the future.

Co-authorship network of co-authors of Thierry Poynard

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Poynard. A scholar is included among the top collaborators of Thierry Poynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Poynard. Thierry Poynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis 2023 ·Alimentary Pharmacology & Therapeutics ·Thierry Poynard, Olivier Deckmyn, Valentina Peta, Valérie Paradis, Jean–François Gautier, (unknown), Pierre Bédossa, Laurent Castéra, Stanislas Pol, Dominique Valla	5
2	Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis 2023 ·Canadian Journal of Gastroenterology and Hepatology ·(unknown), (unknown), Viola Knop, Ursula Heß, (unknown), Jordis Trischler, Thierry Poynard, Ralf Schubert, Stefan Zielen	3
3	Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis 2021 ·Digestive and Liver Disease ·(unknown), (unknown), (unknown), M. Munteanu, An Ngo, Yen Ngo, Thierry Poynard, Dominique Thabut, Marika Rudler	6
4	External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV 2021 ·JHEP Reports ·Thierry Poynard, (unknown), Olivier Deckmyn, Valentina Peta, Sepideh Akhavan, Victor de Lédinghen, Fabien Zoulim, Didier Samuel, Philippe Mathurin, Vlad Ratziu, Dominique Thabut, Chantal Housset, Hélène Fontaine, Stanislas Pol, Fabrice Carrat	4
5	Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference 2016 ·Alimentary Pharmacology & Therapeutics ·M. Munteanu, Dina Tiniakos, Quentin M. Anstee, Frédéric Charlotte, Giulio Marchesini, Elisabetta Bugianesi, Michael Trauner, (unknown), Cláudia P. Oliveira, Christopher P. Day, Jean‐François Dufour, Stefano Bellentani, Yen Ngo, (unknown), Hugo Perazzo, Olivier Deckmyn, Pierre Bédossa, Vlad Ratziu, Thierry Poynard	69
6	Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity 2015 ·BMJ Open ·Thierry Poynard, Olivier Deckmyn, M. Munteanu, Yen Ngo, Fabienne Drane, (unknown), Chantal Housset, Vlad Ratziu	8
7	Hepatitis E infection in patients with severe alcoholic hepatitis 2015 ·European Journal of Gastroenterology & Hepatology ·Marika Rudler, Vincent Thibault, (unknown), Sepideh Akhavan, Maxime Mallet, Frédéric Charlotte, Thierry Poynard, Dominique Thabut	3
8	Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient 2015 ·International Journal of Infectious Diseases ·Aurélie Renvoisé, Nadine Lemaître, (unknown), Hédi Benosman, (unknown), Loïc Epelboin, Vincent Jarlier, Thierry Poynard, Dominique Thabut	2
9	Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: “APRI c’est fini ?” 2014 ·Clinics and Research in Hepatology and Gastroenterology ·Hugo Perazzo, Raluca Pais, M. Munteanu, Yen Ngo, Denis Monneret, Françoise Imbert‐Bismut, J. Moussalli, Pascal Lebray, Yves Benhamou, Dominique Thabut, Vlad Ratziu, (unknown), Thierry Poynard	5
10	Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding 2014 ·Journal of Hepatology ·Marika Rudler, (unknown), Frédéric Charlotte, Pascal Lebray, (unknown), Hédi Benosman, Thierry Poynard, Dominique Thabut	25
11	Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up 2013 ·Journal of Clinical Virology ·Ruxandra Câlin, Marguerite Guiguet, Nathalie Désiré, Françoise Imbert‐Bismut, M. Munteanu, Thierry Poynard, Marc Antoine Valantin, (unknown), Christine Katlama, Vincent Thibault	7
12	Assessment of liver fibrosis: Noninvasive means 2008 ·Saudi Journal of Gastroenterology ·Thierry Poynard, Rachel Morra, Patrick Ingiliz, Françoise Imbert‐Bismut, Dominique Thabut, Djamila Messous, M. Munteanu, Julien Massard, Yves Benhamou, Vlad Ratziu	31
13	Peut-on traiter la stéatohépatite métabolique ? 2007 ·Gastroentérologie Clinique et Biologique ·Vlad Ratziu, (unknown), Mohamed Tahiri, Luminita Bonyhay, (unknown), (unknown), Thierry Poynard, Pascal Lebray	1
14	Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? 2000 ·Hepatology ·Thierry Poynard, John G. McHutchison, Zachary Goodman, Mei-Hsiu Ling, Janice K. Albrecht	297
15	[Pro-inflammatory cytokines in the pathogenesis of alcoholic hepatitis]. 1998 ·PubMed ·Philippe Mathurin, Nathalie Ganne‐Carrié, Thierry Poynard, (unknown)	6
16	Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity 1998 ·Hepatology ·Philippe Mathurin, J. Moussalli, Jean–François Cadranel, Vincent Thibault, Frédéric Charlotte, Patrice Dumouchel, Alain Cazier, Jean‐Marie Huraux, Bruno Devergie, Michel Vidaud, P Opolon, Thierry Poynard	252
17	Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon. 1993 ·Gut ·Pierre Bédossa, Thierry Poynard, Philippe Mathurin, G Lemaigre, J C Chaput	23
18	A Randomized Trial of Prednisolone in Patients with Severe Alcoholic Hepatitis 1992 ·New England Journal of Medicine ·Marie-José Ramond, Thierry Poynard, B Rueff, Philippe Mathurin, C Théodore, Jean‐Claude Chaput, Jean‐Pierre Benhamou	273
19	Risk of Hepatic Vein Thrombosis in Relation to Recent Use of Oral Contraceptives 1986 ·Gastroenterology ·Dominique Valla, Monique G. Lê, Thierry Poynard, (unknown), B Rueff, Jean‐Pierre Benhamou	46
20	[Analysis of factors related to length of stay in the hospital in a hepato-gastroenterology unit]. 1983 ·PubMed ·Thierry Poynard, (unknown), S. Naveau, (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact